Capsule fluconazole 150mg - About fluconazole

Fluconazole Diflucan is designated chemically as 2,4-difluoro-a,a1-bis 1H-1,2,4-triazol-l-ylmethyl benzyl alcohol with an empirical formula of C13H12F2N6O and a molecular weight of Fluconazole is a white crystalline capsule which is slightly soluble in water 150mg saline.

Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, capsule fluconazole 150mg, anti-infective therapy should be adjusted accordingly, capsule fluconazole 150mg.

Fluconazole 150mg 1 Capsule Thrush Treatment

Cryptococcosis, including cryptococcal meningitis and infections of other sites eg, pulmonary, capsule fluconazole 150mg, cutaneous.

Normal hosts and patients with AIDS, organ transplants or other causes of immunosuppression may be capsule. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal disease arcoxia 30mg bijsluiter patients with AIDS. Systemic candidiasis, including candidemia, disseminated candidiasis and other forms of capsule candidal infection.

These include infections of the peritoneum, endocardium, eye, and pulmonary and urinary tracts. Patients 150mg malignancy, in intensive care units, receiving cytotoxic or immunosuppressive therapy, or with other factors predisposing to candidal infection may be treated.

These include fluconazole, esophageal, noninvasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis denture sore mouth. Normal hosts and patients with compromised immune fluconazole may be treated, capsule fluconazole 150mg.

Prevention of relapse of oropharyngeal candidiasis in patients with AIDS. Prevention of capsule infections in patients with malignancy who are predisposed to such infections as a result of cytotoxic chemotherapy or radiotherapy. Dermatomycosis including tinea pedis, tinea corporis, capsule fluconazole 150mg, tinea cruris, capsule fluconazole 150mg, tinea 150mg, tinea unguium onychomycosis and dermal candidal infections.

Deep endemic mycoses in immunocompetent patients, coccidioidomycosis, paracoccidioidomycosis, sporotrichosis and histoplasmosis. fluconazole

May be taken with or without food. Patients with known sensitivity to Diflucan, any of the inert ingredients eg, lactose, maize starch, colloidal silicon dioxide, magnesium fluconazole and sodium lauryl sulphate for fluconazole Diflucan capsules or parenteral grade sodium chloride 9 mg for fluconazole Diflucan solution for injection, or to related azole compounds. Co-administration of other drugs known to prolong the QT interval and which are metabolized via the enzyme CYP3A4 eg, cisapride, astemizole, erythromycin, pimozide and quinidine are contraindicated in patients receiving 150mg see Precautions and Interactions.

Fluconazole should be administered with caution to patients with liver dysfunction. Fluconazole has been associated with capsule cases of serious hepatic toxicity including fatalities, primarily in patients with serious underlying medical conditions.

In cases of fluconazole-associated hepatotoxicity, no obvious relationship to capsule daily dose, duration of therapy, sex or age of patient has been observed.

Fluconazole hepatotoxicity has usually been reversible on discontinuation of therapy. Patients who develop abnormal liver function tests during fluconazole therapy should be monitored for the development of more serious 150mg injury. Fluconazole should be discontinued if clinical signs or symptoms consistent with liver disease develop that may be attributable to fluconazole.

Patients have rarely developed exfoliative cutaneous reactions eg, Stevens-Johnson syndrome and toxic epidermal necrolysis, during treatment with fluconazole.

AIDS patients are more prone to the development of severe cutaneous reactions to many drugs. If a rash, capsule fluconazole 150mg, which is considered attributable to fluconazole, develops in a patient treated for a superficial fungal infection, further therapy with this fluconazole should be discontinued.

DESCRIPTION

In rare cases, as with other azoles, anaphylaxis has been reported, capsule fluconazole 150mg. Some azoles, including fluconazole, have been associated with prolongation of the QT interval on the electrocardiogram. During the post-marketing surveillance, there have been very rare cases of QT prolongation and torsade de pointes in patients taking fluconazole.

What Is The Use Of Fluconazole?

fluconazole These reports included seriously ill patients with multiple confounding fluconazole factors, capsule fluconazole 150mg, eg, structural heart disease, electrolyte abnormalities and concomitant medications that may have been contributory. Fluconazole should be administered with caution to patients with these potentially proarrythmic conditions. Fluconazole capsule patients who are concomitantly treated with drugs with a narrow therapeutic window metabolised through CYP2C9 and CYP3A4 should be monitored see Interactions.

Fluconazole Diflucan capsules contain lactose and should not be capsule to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Fluconazole Diflucan solution for injection contains 2 mg and 90 mg of fluconazole and parenteral grade sodium chloride respectively in sufficient amount of 150mg for injection. Effects on the Ability to Drive or Operate Machinery: When 150mg vehicles or operating machines, capsule fluconazole 150mg, it should be taken into account that occasional dizziness or seizures may occur.